The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP

Nucleic Acids Research

Volumn 40, Issue 13, 2012, Pages 5910-5925

  Wurm, Torsten ^a   Wright, Diana G ^a   Polakowski, Nicholas ^a   Mesnard, Jean Michel ^b   Lemasson, Isabelle ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; LYSINE; PROTEIN HBZ; PROTEIN P53; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTONE ACETYLATION; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RETROVIRUS INFECTION; VIRUS CELL INTERACTION;

ACETYLATION; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; CURCUMIN; ENZYME INHIBITORS; HELA CELLS; HISTONES; HUMANS; P300-CBP TRANSCRIPTION FACTORS; PROTEIN INTERACTION DOMAINS AND MOTIFS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84864451818     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks244     Document Type: Article

References (102)

1. Chan, H.M. and La Thangue, N.B. (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell. Sci., 114, 2363-2373.
2. Arany, Z., Sellers, W.R., Livingston, D.M. and Eckner, R. (1994) E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell, 77, 799-800.
3. Bedford, D.C., Kasper, L.H., Fukuyama, T. and Brindle, P.K. (2010) Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics, 5, 9-15.
4. Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature, 384, 641-643.
5. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
6. Wang, L., Tang, Y., Cole, P.A. and Marmorstein, R. (2008) Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr. Opin. Struct. Biol., 18, 741-747.
7. Hebbes, T.R., Thorne, A.W. and Crane-Robinson, C. (1988) A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J., 7, 1395-1402.
8. Brownell, J.E. and Allis, C.D. (1996) Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev., 6, 176-184.
9. Spange, S., Wagner, T., Heinzel, T. and Kramer, O.H. (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol., 41, 185-198.
10. Schiltz, R.L., Mizzen, C.A., Vassilev, A., Cook, R.G., Allis, C.D. and Nakatani, Y. (1999) Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem., 274, 1189-1192.
11. Sterner, D.E. and Berger, S.L. (2000) Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev., 64, 435-459.
12. Jin, Q., Yu, L.R., Wang, L., Zhang, Z., Kasper, L.H., Lee, J.E., Wang, C., Brindle, P.K., Dent, S.Y. and Ge, K. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J., 30, 249-262.
13. Das, C., Lucia, M.S., Hansen, K.C. and Tyler, J.K. (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature, 459, 113-117.
14. Iyer, N.G., Ozdag, H. and Caldas, C. (2004) p300/CBP and cancer. Oncogene, 23, 4225-4231.
15. Kung, A.L., Rebel, V.I., Bronson, R.T., Ch'ng, L.E., Sieff, C.A., Livingston, D.M. and Yao, T.P. (2000) Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev., 14, 272-277.
16. Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T. and Ishii, S. (1997) Abnormal skeletal patterning in embryos lacking a single CBP allele: a partial similarity with Rubinstein-Taybi syndrome. Proc. Natl Acad. Sci. USA, 94, 10215-10220.
17. Roelfsema, J.H. and Peters, D.J. (2007) Rubinstein-Taybi syndrome: clinical and molecular overview. Expert. Rev. Mol. Med., 9, 1-16.
18. Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L.H., Lerach, S., Tang, H., Ma, J. et al. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature, 471, 189-195.
19. Morin, R.D., Mendez-Lago, M., Mungall, A.J., Goya, R., Mungall, K.L., Corbett, R.D., Johnson, N.A., Severson, T.M., Chiu, R., Field, M. et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298-303.
20. Cerchietti, L.C., Hatzi, K., Caldas-Lopes, E., Yang, S.N., Figueroa, M.E., Morin, R.D., Hirst, M., Mendez, L., Shaknovich, R., Cole, P.A. et al. (2010) BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. J. Clin. Invest., 120, 4569-4582.
21. Mullighan, C.G., Zhang, J., Kasper, L.H., Lerach, S., Payne-Turner, D., Phillips, L.A., Heatley, S.L., Holmfeldt, L., Collins-Underwood, J.R., Ma, J. et al. (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature, 471, 235-239.
22. Kurdistani, S.K. (2011) Histone modifications in cancer biology and prognosis. Prog. Drug Res., 67, 91-106.
23. Seligson, D.B., Horvath, S., McBrian, M.A., Mah, V., Yu, H., Tze, S., Wang, Q., Chia, D., Goodglick, L. and Kurdistani, S.K. (2009) Global levels of histone modifications predict prognosis in different cancers. Am J. Pathol., 174, 1619-1628.
24. Seligson, D.B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M. and Kurdistani, S.K. (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435, 1262-1266.
25. Manuyakorn, A., Paulus, R., Farrell, J., Dawson, N.A., Tze, S., Cheung-Lau, G., Hines, O.J., Reber, H., Seligson, D.B., Horvath, S. et al. (2009) Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J. Clin. Oncol., 28, 1358-1365.
26. Elsheikh, S.E., Green, A.R., Rakha, E.A., Powe, D.G., Ahmed, R.A., Collins, H.M., Soria, D., Garibaldi, J.M., Paish, C.E., Ammar, A.A. et al. (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res., 69, 3802-3809.
27. Mosashvilli, D., Kahl, P., Mertens, C., Holzapfel, S., Rogenhofer, S., Hauser, S., Buttner, R., Von Ruecker, A., Muller, S.C. and Ellinger, J. (2010) Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma. Cancer Sci., 101, 2664-2669.
28. Puppin, C., Passon, N., Lavarone, E., Di Loreto, C., Frasca, F., Vella, V., Vigneri, R. and Damante, G. (2011) Levels of histone acetylation in thyroid tumors. Biochem. Biophys. Res. Commun., 411, 679-683.
29. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D. and Gallo, R.C. (1980) Detection and isolation of type C retrovirus particle from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA, 77, 7415-7419.
30. Yoshida, M., Miyoshi, I. and Hinuma, Y. (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad. Sci. USA, 79, 2031-2035.
31. Goncalves, D.U., Proietti, F.A., Ribas, J.G., Araujo, M.G., Pinheiro, S.R., Guedes, A.C. and Carneiro-Proietti, A.B. (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin. Microbiol. Rev., 23, 577-589.
32. Kannian, P. and Green, P.L. (2010) Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis. Viruses, 2, 2037-2077.
33. Satou, Y., Yasunaga, J., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P.L., Ohkura, N. et al. (2011) HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog, 7, e1001274.
34. Basbous, J., Arpin, C., Gaudray, G., Piechaczyk, M., Devaux, C. and Mesnard, J.M. (2003) The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and C-Jun and modulates their transcriptional activity. J. Biol. Chem., 278, 43620-46327.
35. Thebault, S., Basbous, J., Hivin, P., Devaux, C. and Mesnard, J.M. (2004) HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett., 562, 165-170.
36. Hivin, P., Basbous, J., Raymond, F., Henaff, D., Arpin-Andre, C., Robert-Hebmann, V., Barbeau, B. and Mesnard, J.M. (2007) The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology, 4, 14.
37. Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C. and Mesnard, J.M. (2002) The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol., 76, 12813-12822.
38. Lemasson, I., Lewis, M.R., Polakowski, N., Hivin, P., Cavanagh, M.H., Thebault, S., Barbeau, B., Nyborg, J.K. and Mesnard, J.M. (2007) Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol., 81, 1543-1553.
39. Clerc, I., Polakowski, N., Andre-Arpin, C., Cook, P., Barbeau, B., Mesnard, J.M. and Lemasson, I. (2008) An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ. J. Biol. Chem., 283, 23903-23913.
40. Cook, P.R., Polakowski, N. and Lemasson, I. (2011) HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP. J. Mol. Biol., 409, 384-398.
41. Polakowski, N., Gregory, H., Mesnard, J.M. and Lemasson, I. (2010) Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain. Retrovirology, 7, 61.
42. Zhao, T., Satou, Y., Sugata, K., Miyazato, P., Green, P.L., Imamura, T. and Matsuoka, M. (2011) HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator. Blood, 118, 1865-1876.
43. Ponting, C.P., Blake, D.J., Davies, K.E., Kendrick-Jones, J. and Winder, S.J. (1996) ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem. Sci., 21, 11-13.
44. Kwok, R.P., Lundblad, J.R., Chrivia, J.C., Richards, J.P., Bachinger, H.P., Brennan, R.G., Roberts, S.G., Green, M.R. and Goodman, R.H. (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature, 370, 223-226.
45. Van Orden, K., Yan, J.P., Ulloa, A. and Nyborg, J.K. (1999) Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene, 18, 3766-3772.
46. Shyu, Y.J., Liu, H., Deng, X. and Hu, C.D. (2006) Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques, 40, 61-66.
47. Boyes, J., Byfield, P., Nakatani, Y. and Ogryzko, V. (1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature, 396, 594-598.
48. Rodriguez, M.S., Thompson, J., Hay, R.T. and Dargemont, C. (1999) Nuclear retention of IkAppABalpha protects it from signal-induced degradation and inhibits nuclear factor kAppAB transcriptional activation. J. Biol. Chem., 274, 9108-9115.
49. Lemasson, I., Polakowski, N.J., Laybourn, P.J. and Nyborg, J.K. (2006) Tax-dependent displacement of nucleosomes during transcriptional activation of human T-cell leukemia virus type 1. J. Biol. Chem., 281, 13075-13082.
50. Lemasson, I., Polakowski, N., Laybourn, P.J. and Nyborg, J.K. (2004) Transcription regulatory complexes bind the human T-cell leukemia virus 5′ and 3′ long terminal repeats to control gene expression. Mol. Cell. Biol., 24, 6117-6126.
51. Lemasson, I., Polakowski, N., Laybourn, P.J. and Nyborg, J.K. (2002) Transcription factor binding and histone modifications on the integrated proviral promoter in HTLV-I-infected T-cells. J. Biol. Chem., 277, 49459-49465.
52. Nelson, J.D., Denisenko, O. and Bomsztyk, K. (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc., 1, 179-185.
53. De Guzman, R.N., Liu, H.Y., Martinez-Yamout, M., Dyson, H.J. and Wright, P.E. (2000) Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP In Process Citation. J. Mol. Biol., 303, 243-253.
54. Legge, G.B., Martinez-Yamout, M.A., Hambly, D.M., Trinh, T., Lee, B.M., Dyson, H.J. and Wright, P.E. (2004) ZZ domain of CBP: an unusual zinc finger fold in a protein interaction module. J. Mol. Biol., 343, 1081-1093.
55. Burge, S., Teufel, D.P., Townsley, F.M., Freund, S.M., Bycroft, M. and Fersht, A.R. (2009) Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation. Proc. Natl Acad. Sci. USA, 106, 3142-3147.
56. Wojciak, J.M., Martinez-Yamout, M.A., Dyson, H.J. and Wright, P.E. (2009) Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J., 28, 948-958.
57. Ferreon, J.C., Lee, C.W., Arai, M., Martinez-Yamout, M.A., Dyson, H.J. and Wright, P.E. (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc. Natl Acad. Sci. USA, 106, 6591-6596.
58. Ferreon, J.C., Martinez-Yamout, M.A., Dyson, H.J. and Wright, P.E. (2009) Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc. Natl Acad. Sci. USA, 106, 13260-13265.
59. He, J., Ye, J., Cai, Y., Riquelme, C., Liu, J.O., Liu, X., Han, A. and Chen, L. (2011) Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly. Nucleic Acids Res., 39, 4464-4474.
60. Cavanagh, M., Landry, S., Audet, B., Arpin-Andre, C., Hivin, P., Pare, M.-E., Thete, J., Wattel, E., Marriott, S.J., Mesnard, J.M. et al. (2006) HTLV-I antisense transcripts initiate in the 3′LTR and are alternatively spliced and polyadenylated. Retrovirology, 3, 15.
61. Murata, K., Hayashibara, T., Sugahara, K., Uemura, A., Yamaguchi, T., Harasawa, H., Hasegawa, H., Tsuruda, K., Okazaki, T., Koji, T. et al. (2006) A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol., 80, 2495-2505.
62. Satou, Y., Yasunaga, J., Yoshida, M. and Matsuoka, M. (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl Acad. Sci. USA, 103, 720-725.
63. Cohen, I., Poreba, E., Kamieniarz, K. and Schneider, R. Histone modifiers in cancer: friends or foes? Genes Cancer, 2, 631-647.
64. Zhang, Q., Yao, H., Vo, N. and Goodman, R.H. (2000) Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP. Proc. Natl Acad. Sci. USA, 97, 14323-14328.
65. Li, G.D., Fang, J.X., Chen, H.Z., Luo, J., Zheng, Z.H., Shen, Y.M. and Wu, Q. (2007) Negative regulation of transcription coactivator p300 by orphan receptor TR3. Nucleic Acids Res., 35, 7348-7359.
66. Zhao, F., McCarrick-Walmsley, R., Akerblad, P., Sigvardsson, M. and Kadesch, T. (2003) Inhibition of p300/CBP by early B-cell factor. Mol. Cell. Biol., 23, 3837-3846.
67. Horwitz, G.A., Zhang, K., McBrian, M.A., Grunstein, M., Kurdistani, S.K. and Berk, A.J. (2008) Adenovirus small E1A alters global patterns of histone modification. Science, 321, 1084-1085.
68. Kasper, L.H., Lerach, S., Wang, J., Wu, S., Jeevan, T. and Brindle, P.K. (2010) CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J., 29, 3660-3672.
69. Griffis, E.R., Xu, S. and Powers, M.A. (2003) Nup98 localizes to both nuclear and cytoplasmic sides of the nuclear pore and binds to two distinct nucleoporin subcomplexes. Mol. Biol. Cell, 14, 600-610.
70. Kouzarides, T. (2007) SnapShot: Histone-modifying enzymes. Cell, 131, 822.
71. Zimmermann, H., Degenkolbe, R., Bernard, H.U. and O'Connor, M.J. (1999) The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J. Virol., 73, 6209-6219.
72. Patel, D., Huang, S.M., Baglia, L.A. and McCance, D.J. (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J., 18, 5061-5072.
73. Thomas, M.C. and Chiang, C.M. (2005) E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol. Cell, 17, 251-264.
74. Chakravarti, D., Ogryzko, V., Kao, H.Y., Nash, A., Chen, H., Nakatani, Y. and Evans, R.M. (1999) A viral mechanism for inhibition of p300 and PCAF acetyLTRansferase activity. Cell, 96, 393-403.
75. Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P.L., Wu, H.Y., Wang, J.Y., Nakatani, Y. and Kedes, L. (1999) Regulation of histone acetyLTRansferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell, 96, 405-413.
76. Balasubramanyam, K., Varier, R.A., Altaf, M., Swaminathan, V., SiddAppA, N.B., Ranga, U. and Kundu, T.K. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyLTRansferase, represses the acetylation of histone/nonhistone proteins and histone acetyLTRansferase-dependent chromatin transcription. J. Biol. Chem., 279, 51163-51171.
77. Macfarlan, T., Parker, J.B., Nagata, K. and Chakravarti, D. (2006) Thanatos-associated protein 7 associates with template activating factor-Ibeta and inhibits histone acetylation to repress transcription. Mol. Endocrinol., 20, 335-347.
78. Hublitz, P., Kunowska, N., Mayer, U.P., Muller, J.M., Heyne, K., Yin, N., Fritzsche, C., Poli, C., Miguet, L., Schupp, I.W. et al. (2005) NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev., 19, 2912-2924.
79. Seo, S.B., McNamara, P., Heo, S., Turner, A., Lane, W.S. and Chakravarti, D. (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell, 104, 119-130.
80. Chen, L.F., Mu, Y. and Greene, W.C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kAppAB. EMBO J., 21, 6539-6548.
81. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
82. Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W. and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12, 2831-2841.
83. Teufel, D.P., Freund, S.M., Bycroft, M. and Fersht, A.R. (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc. Natl Acad. Sci. USA, 104, 7009-7014.
84. Fritsche, M., Haessler, C. and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
85. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A. and Green, D.R. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kAppA B and AP-1. Mol. Cell, 1, 543-551.
86. Zhao, T., Yasunaga, J., Satou, Y., Nakao, M., Takahashi, M., Fujii, M. and Matsuoka, M. (2009) Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kAppAB. Blood, 113, 2755-2764.
87. Kwok, R.P., Laurance, M.E., Lundblad, J.R., Goldman, P.S., Shih, H., Connor, L.M., Marriott, S.J. and Goodman, R.H. (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature, 380, 642-646.
88. Lemasson, I. and Nyborg, J.K. (2001) Human T-cell leukemia virus type I Tax repression of p73beta is mediated through competition for the C/H1 domain of CBP. J. Biol. Chem., 276, 15720-15727.
89. Scoggin, K.E., Ulloa, A. and Nyborg, J.K. (2001) The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol. Cell. Biol., 21, 5520-5530.
90. O'Connor, M.J., Zimmermann, H., Nielsen, S., Bernard, H.U. and Kouzarides, T. (1999) Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J. Virol., 73, 3574-3581.
91. Reid, R.L., Lindholm, P.F., Mireskandari, A., Dittmer, J. and Brady, J.N. (1993) Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene, 8, 3029-3036.
92. Akagi, T., Ono, H., Tsuchida, N. and Shimotohno, K. (1997) Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1. FEBS Lett., 406, 263-266.
93. Cereseto, A., Diella, F., Mulloy, J.C., Cara, A., Michieli, P., Grassmann, R., Franchini, G. and Klotman, M.E. (1996) p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood, 88, 1551-1560.
94. Gartenhaus, R.B. and Wang, P. (1995) Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia, 9, 2082-2086.
95. Takemoto, S., Trovato, R., Cereseto, A., Nicot, C., Kislyakova, T., Casareto, L., Waldmann, T., Torelli, G. and Franchini, G. (2000) p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells. Blood, 95, 3939-3944.
96. Tang, Y., Zhao, W., Chen, Y., Zhao, Y. and Gu, W. (2008) Acetylation is indispensable for p53 activation. Cell, 133, 612-626.
97. Rasti, M., Grand, R.J., Mymryk, J.S., Gallimore, P.H. and Turnell, A.S. (2005) Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A. J. Virol., 79, 5594-5605.
98. Dion, M.F., Altschuler, S.J., Wu, L.F. and Rando, O.J. (2005) Genomic characterization reveals a simple histone H4 acetylation code. Proc. Natl Acad. Sci. USA, 102, 5501-5506.
99. Korzus, E., Torchia, J., Rose, D.W., Xu, L., Kurokawa, R., McInerney, E.M., Mullen, T.M., Glass, C.K. and Rosenfeld, M.G. (1998) Transcription factor-specific requirements for coactivators and their acetyLTRansferase functions. Science, 279, 703-707.
100. Puri, P.L., Avantaggiati, M.L., Balsano, C., Sang, N., Graessmann, A., Giordano, A. and Levrero, M. (1997) p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J., 16, 369-383.
101. Ferrari, R., Pellegrini, M., Horwitz, G.A., Xie, W., Berk, A.J. and Kurdistani, S.K. (2008) Epigenetic reprogramming by adenovirus E1A. Science, 321, 1086-1088.
102. Ogiwara, H., Ui, A., Otsuka, A., Satoh, H., Yokomi, I., Nakajima, S., Yasui, A., Yokota, J. and Kohno, T. (2011) Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. Oncogene, 30, 2135-2146.